Literature DB >> 24291591

A support vector machine for predicting defibrillation outcomes from waveform metrics.

Andrew Howe1, Omar J Escalona2, Rebecca Di Maio3, Bertrand Massot4, Nick A Cromie5, Karen M Darragh5, Jennifer Adgey5, David J McEneaney1.   

Abstract

BACKGROUND: Algorithms to predict shock success based on VF waveform metrics could significantly enhance resuscitation by optimising the timing of defibrillation.
OBJECTIVE: To investigate robust methods of predicting defibrillation success in VF cardiac arrest patients, by using a support vector machine (SVM) optimisation approach.
METHODS: Frequency-domain (AMSA, dominant frequency and median frequency) and time-domain (slope and RMS amplitude) VF waveform metrics were calculated in a 4.1Y window prior to defibrillation. Conventional prediction test validity of each waveform parameter was conducted and used AUC>0.6 as the criterion for inclusion as a corroborative attribute processed by the SVM classification model. The latter used a Gaussian radial-basis-function (RBF) kernel and the error penalty factor C was fixed to 1. A two-fold cross-validation resampling technique was employed.
RESULTS: A total of 41 patients had 115 defibrillation instances. AMSA, slope and RMS waveform metrics performed test validation with AUC>0.6 for predicting termination of VF and return-to-organised rhythm. Predictive accuracy of the optimised SVM design for termination of VF was 81.9% (± 1.24 SD); positive and negative predictivity were respectively 84.3% (± 1.98 SD) and 77.4% (± 1.24 SD); sensitivity and specificity were 87.6% (± 2.69 SD) and 71.6% (± 9.38 SD) respectively.
CONCLUSIONS: AMSA, slope and RMS were the best VF waveform frequency-time parameters predictors of termination of VF according to test validity assessment. This a priori can be used for a simplified SVM optimised design that combines the predictive attributes of these VF waveform metrics for improved prediction accuracy and generalisation performance without requiring the definition of any threshold value on waveform metrics.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CPR; Cardiac arrest; Defibrillation; Resuscitation therapy; Support vector machine (SVM); VF waveform metrics

Mesh:

Year:  2013        PMID: 24291591     DOI: 10.1016/j.resuscitation.2013.11.021

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  9 in total

1.  Ventricular Fibrillation Waveform Analysis During Chest Compressions to Predict Survival From Cardiac Arrest.

Authors:  Jason Coult; Jennifer Blackwood; Lawrence Sherman; Thomas D Rea; Peter J Kudenchuk; Heemun Kwok
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-01

2.  Combining Amplitude Spectrum Area with Previous Shock Information Using Neural Networks Improves Prediction Performance of Defibrillation Outcome for Subsequent Shocks in Out-Of-Hospital Cardiac Arrest Patients.

Authors:  Mi He; Yubao Lu; Lei Zhang; Hehua Zhang; Yushun Gong; Yongqin Li
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

3.  Fuzzy and Sample Entropies as Predictors of Patient Survival Using Short Ventricular Fibrillation Recordings during out of Hospital Cardiac Arrest.

Authors:  Beatriz Chicote; Unai Irusta; Elisabete Aramendi; Raúl Alcaraz; José Joaquín Rieta; Iraia Isasi; Daniel Alonso; María Del Mar Baqueriza; Karlos Ibarguren
Journal:  Entropy (Basel)       Date:  2018-08-09       Impact factor: 2.524

4.  MLWAVE: A novel algorithm to classify primary versus secondary asphyxia-associated ventricular fibrillation.

Authors:  Dieter Bender; Ryan W Morgan; Vinay M Nadkarni; Robert A Berg; Bingqing Zhang; Todd J Kilbaugh; Robert M Sutton; C Nataraj
Journal:  Resusc Plus       Date:  2020-12-14

Review 5.  Role of artificial intelligence in defibrillators: a narrative review.

Authors:  Grace Brown; Samuel Conway; Mahmood Ahmad; Divine Adegbie; Nishil Patel; Vidushi Myneni; Mohammad Alradhawi; Niraj Kumar; Daniel R Obaid; Dominic Pimenta; Jonathan J H Bray
Journal:  Open Heart       Date:  2022-07

Review 6.  [Adult advanced life support].

Authors:  Jasmeet Soar; Bernd W Böttiger; Pierre Carli; Keith Couper; Charles D Deakin; Therese Djärv; Carsten Lott; Theresa Olasveengen; Peter Paal; Tommaso Pellis; Gavin D Perkins; Claudio Sandroni; Jerry P Nolan
Journal:  Notf Rett Med       Date:  2021-06-08       Impact factor: 0.826

7.  Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Jasmeet Soar; Katherine M Berg; Lars W Andersen; Bernd W Böttiger; Sofia Cacciola; Clifton W Callaway; Keith Couper; Tobias Cronberg; Sonia D'Arrigo; Charles D Deakin; Michael W Donnino; Ian R Drennan; Asger Granfeldt; Cornelia W E Hoedemaekers; Mathias J Holmberg; Cindy H Hsu; Marlijn Kamps; Szymon Musiol; Kevin J Nation; Robert W Neumar; Tonia Nicholson; Brian J O'Neil; Quentin Otto; Edison Ferreira de Paiva; Michael J A Parr; Joshua C Reynolds; Claudio Sandroni; Barnaby R Scholefield; Markus B Skrifvars; Tzong-Luen Wang; Wolfgang A Wetsch; Joyce Yeung; Peter T Morley; Laurie J Morrison; Michelle Welsford; Mary Fran Hazinski; Jerry P Nolan
Journal:  Resuscitation       Date:  2020-10-21       Impact factor: 5.262

8.  Combining multiple ECG features does not improve prediction of defibrillation outcome compared to single features in a large population of out-of-hospital cardiac arrests.

Authors:  Mi He; Yushun Gong; Yongqin Li; Tommaso Mauri; Francesca Fumagalli; Marcella Bozzola; Giancarlo Cesana; Roberto Latini; Antonio Pesenti; Giuseppe Ristagno
Journal:  Crit Care       Date:  2015-12-10       Impact factor: 9.097

9.  Computerized Analysis of the Ventricular Fibrillation Waveform Allows Identification of Myocardial Infarction: A Proof-of-Concept Study for Smart Defibrillator Applications in Cardiac Arrest.

Authors:  Jos Thannhauser; Joris Nas; Dennis J Rebergen; Sjoerd W Westra; Joep L R M Smeets; Niels Van Royen; Judith L Bonnes; Marc A Brouwer
Journal:  J Am Heart Assoc       Date:  2020-10-02       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.